{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T22:33:11Z","timestamp":1649111591738},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/mop.0b013e3283557ceb","type":"journal-article","created":{"date-parts":[[2012,6,15]],"date-time":"2012-06-15T11:00:43Z","timestamp":1339758043000},"page":"494-497","source":"Crossref","is-referenced-by-count":0,"title":["Endocrinology and metabolism 2012"],"prefix":"10.1097","volume":"24","author":[{"given":"Allen W.","family":"Root","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-11-20210206","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/HCO.0b013e3283129b89","article-title":"Aortic dissection in Turner syndrome.","volume":"23","author":"Bondy","year":"2008","journal-title":"Curr Opin Cardiol"},{"key":"R2-11-20210206","doi-asserted-by":"crossref","first-page":"E260","DOI":"10.1210\/jc.2010-0925","article-title":"Materno-fetal cardiovascular complications in Turner syndrome after oocyte donation: insufficient prepregnancy screening and pregnancy follow-up are associated with poor outcome.","volume":"96","author":"Chevalier","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R3-11-20210206","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1532-429X-13-24","article-title":"Dilatation of the ascending aorta in Turner syndrome - a prospective cardiovascular magnetic resonance study.","volume":"13","author":"Mortensen","year":"2011","journal-title":"J Cardiovasc Magn Reson"},{"key":"R4-11-20210206","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1210\/jc.2009-1754","article-title":"Impact of growth hormone therapy on quality of life in adults with Turner syndrome.","volume":"95","author":"Amundson","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-11-20210206","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/nature09410","article-title":"Hundreds of variants clustered in genomic loci and biological pathways affect human height.","volume":"467","author":"Weedon","year":"2010","journal-title":"Nature"},{"key":"R6-11-20210206","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/er.2011-0001","article-title":"Mechanisms limiting body growth in mammals.","volume":"32","author":"Liu","year":"2011","journal-title":"Endocr Rev"},{"key":"R7-11-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-010-1024-2","article-title":"Hormone-like (endocrine) FGFs: their evolutionary history and roles in development, metabolism, and disease.","volume":"342","author":"Itoh","year":"2010","journal-title":"Cell Tissue Res"},{"key":"R8-11-20210206","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling aging.","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"R9-11-20210206","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1073\/pnas.0913986107","article-title":"Relevant use of klotho in FGF19 subfamily signaling system in vivo.","volume":"107","author":"Tomiyama","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R10-11-20210206","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1126\/science.1198363","article-title":"FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis.","volume":"331","author":"Kir","year":"2011","journal-title":"Science"},{"key":"R11-11-20210206","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1204504","article-title":"Selective insulin sensitizers.","volume":"331","author":"Kim-Muller","year":"2011","journal-title":"Science"},{"key":"R12-11-20210206","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1517\/14728222.2011.624514","article-title":"Therapeutic utilities of fibroblast growth factor 19.","volume":"15","author":"Wu","year":"2011","journal-title":"Expert Opin Ther Targets"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0b013e3283557ceb","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:42:14Z","timestamp":1620963734000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008480-201208000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0b013e3283557ceb","relation":{},"ISSN":["1040-8703"],"issn-type":[{"value":"1040-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}